126 related articles for article (PubMed ID: 6624772)
1. Computed tomographic scanning versus radioisotope imaging in adrenocortical diagnosis.
Guerin CK; Wahner HW; Gorman CA; Carpenter PC; Sheedy PF
Am J Med; 1983 Oct; 75(4):653-7. PubMed ID: 6624772
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical scintigraphy.
Troncone L; Danza FM
Rays; 1992; 17(1):34-9. PubMed ID: 1636016
[No Abstract] [Full Text] [Related]
3. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
[TBL] [Abstract][Full Text] [Related]
4. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
Barliev GB
Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of adrenal venography and iodocholesterol scan in adrenal surgery.
Herwig KR; Sonda LP
J Urol; 1979 Jul; 122(1):7-8. PubMed ID: 458994
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas.
Thompson NW; Cheung PS
Surg Clin North Am; 1987 Apr; 67(2):423-36. PubMed ID: 3551152
[TBL] [Abstract][Full Text] [Related]
7. Radiocholesterol scintigraphy in Cushing's syndrome.
Rufini V; Saletnich I; Troncone L
Rays; 1992; 17(1):40-8. PubMed ID: 1636017
[No Abstract] [Full Text] [Related]
8. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma.
Ruíz Hernández G; Pallarés FJ; Bartual AR; Tenes Rodrigo S; Ampudia-Blasco FJ; de Avila y Avalos CR
Nuklearmedizin; 1998 Jun; 37(4):141-5. PubMed ID: 9650214
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphy with 131I-19-iodocholesterol in adrenal disease.
Jorgensen H; Norman N; Sundsfjord JA
Acta Med Scand; 1975 May; 197(5):345-51. PubMed ID: 1146612
[TBL] [Abstract][Full Text] [Related]
11. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
[TBL] [Abstract][Full Text] [Related]
12. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
13. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic imaging of endocrine diseases. Adrenal cortex neoplasms].
Hanew K; Yoshinaga K
Nihon Rinsho; 1987 Nov; 45(11):2493-500. PubMed ID: 3444045
[No Abstract] [Full Text] [Related]
15. Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
Yu KC; Fraker DL; Ziessman HA
Clin Nucl Med; 1996 Feb; 21(2):136-41. PubMed ID: 8697685
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
17. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
Taillefer R; Soucy JP; Eybalin MC; Levasseur A
J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
[TBL] [Abstract][Full Text] [Related]
18. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
[No Abstract] [Full Text] [Related]
19. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
[TBL] [Abstract][Full Text] [Related]
20. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
